2022
DOI: 10.1007/s10048-022-00690-9
|View full text |Cite
|
Sign up to set email alerts
|

Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A > C

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 65 publications
2
9
0
Order By: Relevance
“…The SGCB p.Thr182Pro variant is more frequent and is present in 146 (12.5%). This variant was also reported in our recent study [13].…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…The SGCB p.Thr182Pro variant is more frequent and is present in 146 (12.5%). This variant was also reported in our recent study [13].…”
Section: Discussionsupporting
confidence: 90%
“…Furthermore, we perform an additional analysis of patients carrying SGCB p.Thr182Pro, which is the more frequent pathogenic variant identified in our study cohort. The SGCB variant was also reported to be the most frequent in our recent study with different sarcoglycanopathies [13]. Analysis identified a large ROH region shared across the patients with SGCB p.Thr182Pro variant.…”
Section: Introductionmentioning
confidence: 62%
See 2 more Smart Citations
“…Among SGCG mutation, 525delT was encountered in 50% of the cases although haplotype analysis has not been undertaken. Recently, Bardhan et al 8 investigated the clinical picture, genetic basis, and disease progression of 68 patients genetically confirmed to have SG. The most common mutation identified was c.544 T > G in SGCB detected in 20 patients (29.42%) from the southern states of Tamil Nadu, Karnataka and Andhra Pradesh in India indicating a founder event leading to the descend of this mutation from a common ancestor.…”
Section: Introductionmentioning
confidence: 99%